FDA suspends medical spa's mammography operations amid 'serious concerns' about quality

The U.S. Food and Drug Administration has ordered a mammography clinic in Sulphur Springs, West Virginia, to suspend operations last week following an evaluation by the American College of Radiology. 

That evaluation determined that the Greenbrier Clinic has failed to requirements established by the Mammography Quality Standards Act. In a letter addressed to patients on March 23, Henry Setliff, MD, the clinic’s radiologist, informed recipients that that FDA had raised “serious concerns” about the quality of exams that were completed over a two-year period.  

Anyone patient who received a mammogram at the clinic between Oct. 28, 2023, and Feb. 26, 2026, is urged to take action, as the exams completed during this window might not be of sufficient quality. As such, this could prevent readers from providing an accurate diagnosis. The exact number of individuals who were affected has not yet been revealed. 

The Greenbrier Clinic is located within the the Greenbrier Resort in White Sulphur Springs, West Virginia. On its website, the clinic bills itself as “the country’s only healthcare facility that combines a full-service diagnostic clinic and ambulatory surgery center with a comprehensive family care practice and world-renowned med spa.” It provides an array of diagnostic testing, in addition to spa services and concierge medical packages. 

The clinic has not yet informed patients of when its mammography services will be restored, but the letter sent to patients indicates it is actively working with the FDA. 

“The Greenbrier Clinic Inc. plans to take the necessary steps to become operational again after we have completed all the required actions to the satisfaction of the FDA and our accreditation body,” Setliff’s letter said.